跳至主要内容
临床试验/JPRN-jRCTs031220119
JPRN-jRCTs031220119招募中1 期

Tolerability of oral nutrition supplementation for interstitial lung disease with a tendency toward weight loss

Abe Mitsuhiro0 个研究点目标入组 3 人开始时间: 2022年6月7日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients diagnosed with interstitial lung disease
  • 2) Patients aged 20 years and over at the time of obtaining consent
  • 3) Patients with weight loss of at least 1 kg in the last 12 months
  • 4) Patients who have been fully informed of the study and have obtained documentation of their own free will with full understanding of their participation in the study.

排除标准

  • 1) Patients with coexisting malignant disease
  • 2) Patients with other diseases such as diabetes causing weight loss
  • 3) Patients already taking oral nutritional supplements at least once a week
  • 4) Patients receiving new medication within the past month for diarrhea as a side effect of antifibrotic drugs
  • 5) Patients allergic to milk, soya and gelatine, which are ingredients of Isocal 100
  • 6) Patients unable to give consent
  • 7) Other patients deemed unsuitable for the safe conduct of the study by the principal investigator or the sub-investigator.

研究者

发起方
Abe Mitsuhiro

相似试验